139 related articles for article (PubMed ID: 35284968)
1. The impact of anti-endothelial cell antibodies (AECAs) on the development of blood vessel damage in patients with systemic lupus erythematosus: the preliminary study.
Cieślik P; Semik-Grabarczyk E; Hrycek A; Holecki M
Rheumatol Int; 2022 May; 42(5):791-801. PubMed ID: 35284968
[TBL] [Abstract][Full Text] [Related]
2. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
Cieślik P; Hrycek A
Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491
[TBL] [Abstract][Full Text] [Related]
3. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
[TBL] [Abstract][Full Text] [Related]
4. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner.
Carvalho D; Savage CO; Isenberg D; Pearson JD
Arthritis Rheum; 1999 Apr; 42(4):631-40. PubMed ID: 10211876
[TBL] [Abstract][Full Text] [Related]
5. [The role of endothelial cells in the pathogenesis of systemic lupus erythematosus].
Robak E; Kierstan MK; Kulczycka L; Sysa-Jedrzejowska A
Postepy Hig Med Dosw (Online); 2007 Jun; 61():413-9. PubMed ID: 17572660
[TBL] [Abstract][Full Text] [Related]
6. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
Kluz J; Kopeć W; Jakobsche U; Prajs I; Adamiec R
Postepy Hig Med Dosw (Online); 2007 Dec; 61():725-35. PubMed ID: 18063917
[TBL] [Abstract][Full Text] [Related]
7. Anti-endothelial cell antibodies in patients with systemic lupus erythematosus.
Liu MF; Lei HY
J Formos Med Assoc; 1991 Mar; 90(3):221-4. PubMed ID: 1677395
[TBL] [Abstract][Full Text] [Related]
8. Markers of vascular damage in lupus pregnancy.
Direskeneli H; Buchanan NM; Khamashta MA; Keser G; D'Cruz D; Hughes GR
Clin Exp Rheumatol; 1997; 15(5):535-9. PubMed ID: 9307862
[TBL] [Abstract][Full Text] [Related]
9. Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients.
Dieudé M; Senécal JL; Raymond Y
Arthritis Rheum; 2004 Oct; 50(10):3221-31. PubMed ID: 15476243
[TBL] [Abstract][Full Text] [Related]
10. Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus.
Song J; Park YB; Lee WK; Lee KH; Lee SK
Rheumatol Int; 2000 Dec; 20(1):1-7. PubMed ID: 11149654
[TBL] [Abstract][Full Text] [Related]
11. A novel autoantibody against fibronectin leucine-rich transmembrane protein 2 expressed on the endothelial cell surface identified by retroviral vector system in systemic lupus erythematosus.
Shirai T; Fujii H; Ono M; Nakamura K; Watanabe R; Tajima Y; Takasawa N; Ishii T; Harigae H
Arthritis Res Ther; 2012 Jul; 14(4):R157. PubMed ID: 22747982
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies directed against labile epitopes on cell surface proteins in autoimmune disease patients: proposal of a novel ELISA for the detection of anti-endothelial cell antibodies.
Miura K; Aoun K; Yoshida S; Kurosawa Y
J Immunol Methods; 2012 Aug; 382(1-2):32-9. PubMed ID: 22580760
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of anti-endothelial cell antibodies in systemic vasculitis: a longitudinal study comparing anti-endothelial cell antibodies and anti-neutrophil cytoplasm antibodies.
Chan TM; Frampton G; Jayne DR; Perry GJ; Lockwood CM; Cameron JS
Am J Kidney Dis; 1993 Sep; 22(3):387-92. PubMed ID: 8372833
[TBL] [Abstract][Full Text] [Related]
14. Vasculopathy and vasculitis in systemic lupus erythematosus.
Cieślik P; Hrycek A; Kłuciński P
Pol Arch Med Wewn; 2008; 118(1-2):57-63. PubMed ID: 18405174
[TBL] [Abstract][Full Text] [Related]
15. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus.
Yoshio T; Masuyama J; Sumiya M; Minota S; Kano S
J Rheumatol; 1994 Nov; 21(11):2058-63. PubMed ID: 7869310
[TBL] [Abstract][Full Text] [Related]
16. Study of anti-endothelial cell antibodies in SLE patients with acute ischemic stroke.
Cojocaru IM; Cojocaru M; Butnaru L; Miu G; Tănăsescu R
Rom J Intern Med; 2010; 48(2):173-7. PubMed ID: 21428182
[TBL] [Abstract][Full Text] [Related]
17. Characterization of anti-endothelial cell antibodies in the patients with systemic lupus erythematosus: a potential marker for disease activity.
Li JS; Liu MF; Lei HY
Clin Immunol Immunopathol; 1996 Jun; 79(3):211-6. PubMed ID: 8635277
[TBL] [Abstract][Full Text] [Related]
18. Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study.
Spronk PE; Bootsma H; Huitema MG; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1994 Sep; 97(3):439-44. PubMed ID: 7521807
[TBL] [Abstract][Full Text] [Related]
19. Human monoclonal anti-endothelial cell IgG-derived from a systemic lupus erythematosus patient binds and activates human endothelium in vitro.
Yazici ZA; Raschi E; Patel A; Testoni C; Borghi MO; Graham AM; Meroni PL; Lindsey N
Int Immunol; 2001 Mar; 13(3):349-57. PubMed ID: 11222504
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis.
D'Cruz DP; Houssiau FA; Ramirez G; Baguley E; McCutcheon J; Vianna J; Haga HJ; Swana GT; Khamashta MA; Taylor JC
Clin Exp Immunol; 1991 Aug; 85(2):254-61. PubMed ID: 1864005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
